|
Index of reports
> Life Threatening Events (30)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 30 Next >>
Possible Reyataz side effects in 52 year old female
Reported by a physician from France on 2012-08-27
Patient: 52 year old female
Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Propranolol; Vitamin A; Truvada; Irbesartan; Ciprofloxacin Hydrochloride; Nexium; Effexor; Norvir
Possible Reyataz side effects in 52 year old female
Reported by a consumer/non-health professional from France on 2012-08-27
Patient: 52 year old female
Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Irbesartan; Effexor; Truvada; Sulfamethoxazole and Trimethoprim; Nexium; Vitamin A; Ciprofloxacin Hydrochloride; Norvir; Propranolol
Possible Reyataz side effects in 35 year old male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 35 year old male
Reactions: Road Traffic Accident
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Carvedilol; Olanzapine; Exforge; Metformin Hydrochloride; Ritonavir; Ibuprofen; Truvada
Possible Reyataz side effects in male
Reported by a physician from France on 2012-08-13
Patient: male
Reactions: Cholelithiasis, Pancreatitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 66 year old female
Reported by a physician from Germany on 2012-08-09
Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Rhabdomyolysis, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: 300 mg (300 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Simvastatin
Dosage: 40 mg (40 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Coronary Artery Disease
Possible Reyataz side effects in 66 year old female
Reported by a individual with unspecified qualification from Germany on 2012-08-07
Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Rhabdomyolysis, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: 300 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Simvastatin
Dosage: 40 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Coronary Artery Disease
Possible Reyataz side effects in 66 year old female
Reported by a physician from Germany on 2012-08-07
Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Rhabdomyolysis, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient possibly interacting with the suspect drug:
Simvastatin
Dosage: for about 10 days
Administration route: Oral
Indication: Coronary Artery Disease
Possible Reyataz side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-02
Patient: male
Reactions: Adverse Event
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Viread
Videx
Reyataz
Norvir
Possible Reyataz side effects in male
Reported by a physician from Russian Federation on 2012-07-03
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-05-12
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-12
Possible Reyataz side effects in
Reported by a pharmacist from Germany on 2012-06-22
Patient:
Reactions: Pneumonia, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in male
Reported by a consumer/non-health professional from France on 2012-06-15
Patient: male
Reactions: Coma, Renal Failure Chronic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ritonavir
Reyataz
Possible Reyataz side effects in
Reported by a consumer/non-health professional from Germany on 2012-06-14
Patient:
Reactions: Adverse Event
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 68 year old male
Reported by a physician from Brazil on 2012-06-13
Patient: 68 year old male, weighing 64.0 kg (140.8 pounds)
Reactions: Weight Decreased, Jaundice, Scratch, Oral Disorder, Depression, Acute Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Indication: HIV Infection
Start date: 2006-01-01
Lamivudine
Indication: HIV Infection
Start date: 2003-01-01
Tenofovir Disoproxil Fumarate
Indication: HIV Infection
Start date: 2006-01-01
Ritonavir
Indication: HIV Infection
Start date: 2006-01-01
Possible Reyataz side effects in
Reported by a consumer/non-health professional from Germany on 2012-05-08
Patient:
Reactions: Adverse Event
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in
Reported by a pharmacist from United States on 2012-04-06
Patient:
Reactions: Road Traffic Accident, Brain Oedema
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 53 year old male
Reported by a pharmacist from United States on 2012-03-26
Patient: 53 year old male
Reactions: Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Lortab; Calcium Carbonate; Xanax; Folic Acid; Ritonavir; Dexamethasone; Ferrous Sulfate TAB; Truvada
Possible Reyataz side effects in 71 year old male
Reported by a pharmacist from Germany on 2012-02-28
Patient: 71 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: 1df:300 unit no reyataz 150
Administration route: Oral
Indication: HIV Infection
Norvir
Dosage: 1df:100 unit nos
Administration route: Oral
Indication: HIV Infection
Abacavir Sulfate / Lamivudine
Dosage: 1df:600/300 unit nos
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Aspirin; Ramipril; Fentanyl; Metoprolol Tartrate; Gabapentin; Norepinephrine Bitartrate; Doxazosin; Hydrochlorothiazide; Esomeprazole Sodium; Torsemide; Zopiclone; Midazolam; Linezolid; Propofol
Possible Reyataz side effects in male
Reported by a physician from United States on 2012-02-06
Patient: male
Reactions: Abdominal Pain, Hepatic Function Abnormal, Hepatitis C, Hyperthermia, Pyrexia, Oesophageal Varices Haemorrhage, Gastritis, Intestinal Mucosal Hypertrophy, Liver Function Test Abnormal, Erosive Oesophagitis, Erosive Duodenitis, Lipoatrophy, Hepatic Cirrhosis, Hepatosplenomegaly, Nausea, Anastomotic Haemorrhage, Ascites, Haemoglobin Decreased, Haematochezia, Staphylococcal Infection, Arthralgia, Arthritis Bacterial, Gastroenteritis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamivudine
Administration route: Oral
Start date: 2005-04-01
End date: 2005-04-24
Lamivudine
Administration route: Oral
Start date: 1997-12-29
End date: 2005-04-24
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2008-07-13
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-07-28
End date: 2005-04-24
Stavudine
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-21
End date: 2005-04-24
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-07-27
Reyataz
Administration route: Oral
Start date: 2004-07-30
End date: 2005-04-24
Norvir
Administration route: Oral
Start date: 2008-07-14
Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Truvada
Start date: 2005-05-24
Other drugs received by patient: Emtricitabine and Tenofovir Disoproxil Fumarate; Glycine; Coagulation Factor Viii; Tenofovir Disoproxil Fumarate; Cysteine; Octocog Alfa; Glycyrrhisinic Acid; Ammonium Glycyrrhizinate; Ammonium Glycyrrhizinate
Possible Reyataz side effects in 31 year old male
Reported by a consumer/non-health professional from United States on 2012-02-01
Patient: 31 year old male
Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Efavirenz
Dosage: therapy start date: 25-apr-2005
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2008-07-13
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-21
End date: 2005-04-24
Truvada
Dosage: tabs; therapy start date: 24-may-2005
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-24
Norvir
Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
Administration route: Oral
Indication: HIV Infection
Start date: 2004-07-28
End date: 2005-04-24
Lamivudine
Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
Administration route: Oral
Indication: HIV Infection
Start date: 1997-12-29
End date: 2005-05-23
Viread
Dosage: tab.
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Reyataz
Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-07-27
Other drugs received by patient: Rabeprazole Sodium; Cysteine; Glycyrrhizinic Acid; Glycine; Kogenate; Octocog Alpha; Ammonium Glycyrrhizinate
Possible Reyataz side effects in 44 year old female
Reported by a physician from Germany on 2012-01-30
Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)
Reactions: Tubulointerstitial Nephritis, Blood Creatinine Increased, Azotaemia, Anuria, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cotrim DS
Dosage: 480mg single dose
Administration route: Oral
Start date: 2011-04-13
End date: 2011-08-19
Reyataz
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-04-20
End date: 2011-08-19
Abacavir Sulfate
Dosage: 1unit per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-07-29
End date: 2011-08-19
Other drugs received by patient: Fluconazole; Ramipril; Citalopram; Adalat; Norvir; Truvada; Bisoprolol Fumarate and Hydrochlorothiazide
Possible Reyataz side effects in 31 year old male
Reported by a physician from United States on 2012-01-27
Patient: 31 year old male
Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Efavirenz
Dosage: therapy start date: 25-apr-2005
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2008-07-13
Reyataz
Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-07-27
Viread
Dosage: tab.
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Norvir
Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
Administration route: Oral
Indication: HIV Infection
Start date: 2004-07-28
End date: 2005-04-24
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-21
End date: 2005-04-24
Lamivudine
Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
Administration route: Oral
Indication: HIV Infection
Start date: 1997-12-29
End date: 2005-05-23
Truvada
Dosage: tabs; therapy start date: 24-may-2005
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-24
Other drugs received by patient: Ammonium Glycyrrhizinate; Kogenate; Octocog Alpha; Rabeprazole Sodium; Glycine; Glycyrrhizinic Acid; Cysteine
Possible Reyataz side effects in 44 year old female
Reported by a consumer/non-health professional from Germany on 2012-01-27
Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)
Reactions: Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: cumulative dose of reyataz to first adverse reaction 32700 mg
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2011-04-20
End date: 2011-08-19
Cotrim DS
Dosage: cumulative dose of cotrim forte to 1st adverse reaction was 58 x 0.5 tabs 1df:0.5tab
Administration route: Oral
Start date: 2011-04-13
End date: 2011-08-19
Norvir
Dosage: (dosage form 82). the cumulative dose of norvir to the first adverse reaction was 10900 mg.
Administration route: Oral
Start date: 2011-04-20
Truvada
End date: 2011-07-28
Abacavir Sulfate
Dosage: tabs 1df=82-units nos cumulative dose of kivexa to 1st adverse reaction was 9 tabs
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2011-07-29
End date: 2011-08-19
Other drugs received by patient: Citalopram Hydrobromide; Ramipril; Bisoprolol Fumarate; Adalat; Fluconazole
Possible Reyataz side effects in 39 year old male
Reported by a consumer/non-health professional from Japan on 2012-01-27
Patient: 39 year old male
Reactions: Hepatic Cirrhosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: 30jan04-27jul04 400 mg (180days). 28jul04-24apr05 300 mg.cap
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-30
End date: 2005-04-24
Epivir
Dosage: also 300mg on 25apr2005-23may2005.tab
Administration route: Oral
Indication: HIV Infection
Start date: 1997-12-29
End date: 2005-05-23
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-21
End date: 2005-04-24
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2008-07-13
Norvir
Dosage: 28jul04-24apr05: 271 days 14jul08-cont.cap. norvir soft
Administration route: Oral
Indication: HIV Infection
Start date: 2004-07-28
Viread
Dosage: tab
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Other drugs received by patient: NEO-Minophagen C; Kogenate; Antihemophilic Factor (Human)
Possible Reyataz side effects in 45 year old female
Reported by a physician from France on 2011-12-13
Patient: 45 year old female
Reactions: Weight Decreased, Drug Resistance, Acute Generalised Exanthematous Pustulosis, Generalised Erythema, Castleman's Disease, Pancytopenia, Anaphylactic Shock, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Norvir
Indication: HIV Infection
Start date: 2010-05-28
End date: 2010-06-01
Sustiva
Administration route: Oral
Prezista
Start date: 2010-05-28
End date: 2010-06-01
Nevirapine
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Isentress
Administration route: Oral
Start date: 2010-08-17
End date: 2010-01-01
Viread
Start date: 2010-05-28
End date: 2010-06-01
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Viread
Start date: 2010-08-11
End date: 2010-08-11
Other drugs received by patient: Piascledine
Possible Reyataz side effects in 50 year old male
Reported by a physician from Spain on 2011-11-24
Patient: 50 year old male
Reactions: Hepatic Neoplasm Malignant, Hepatitis C, Cholestasis, Hepatic Cirrhosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: total dose 400mg
Administration route: Oral
Indication: HIV Infection
Start date: 2007-01-01
End date: 2010-12-06
Esomeprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-10-29
End date: 2010-12-02
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2010-12-06
Other drugs received by patient: Sumial; Diazepam
Possible Reyataz side effects in 45 year old female
Reported by a physician from France on 2011-11-23
Patient: 45 year old female
Reactions: Weight Decreased, Drug Resistance, Generalised Erythema, Acute Generalised Exanthematous Pustulosis, Castleman's Disease, Anaphylactic Shock, Pancytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Norvir
Indication: HIV Infection
Start date: 2010-05-28
End date: 2010-06-01
Viread
Start date: 2010-08-11
End date: 2010-08-11
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Prezista
Start date: 2010-05-28
End date: 2010-06-01
Isentress
Administration route: Oral
Start date: 2010-08-17
End date: 2010-01-01
Sustiva
Administration route: Oral
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Viread
Start date: 2010-05-28
End date: 2010-06-01
Nevirapine
Other drugs received by patient: Piascledine
Possible Reyataz side effects in 45 year old female
Reported by a consumer/non-health professional from France on 2011-11-20
Patient: 45 year old female
Reactions: Weight Decreased, Acute Generalised Exanthematous Pustulosis, Drug Resistance, Castleman's Disease, Pancytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: reintroduced on 19aug10
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Prezista
Isentress
Dosage: reintroduced 17aug10,isentress 400mg film-coated tablet.
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Efavirenz
Viread
Start date: 2010-08-11
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Norvir
Indication: HIV Infection
Start date: 2010-05-28
Other drugs received by patient: Piascledine
Possible Reyataz side effects in 50 year old male
Reported by a physician from Spain on 2011-11-15
Patient: 50 year old male
Reactions: Cholestasis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Esomeprazol / 01479301 /
Dosage: 20 mg, qd
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-10-29
End date: 2010-12-02
Nexavar
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2010-10-29
End date: 2010-12-02
Reyataz
Dosage: 400 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2007-01-01
End date: 2010-12-06
Truvada
Dosage: 245 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2010-12-06
Other drugs received by patient: Diazepam; Sumial
Possible Reyataz side effects in 50 year old male
Reported by a physician from Spain on 2011-11-14
Patient: 50 year old male
Reactions: Blood Bilirubin Increased, Musculoskeletal Pain, Cholestasis, Terminal State
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Nexavar
Dosage: 400 mg, hs
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2010-10-29
End date: 2010-12-02
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2007-01-01
End date: 2010-12-06
Esomeprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-10-29
End date: 2010-12-02
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2010-12-06
Other drugs received by patient: Sumial; Diazepam
Possible Reyataz side effects in
Reported by a pharmacist from United States on 2011-11-02
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Baraclude
Indication: Hepatitis B
Reyataz
Indication: HIV Infection
Other drugs received by patient: Efavirenz; Isentress
Page 1 Next >>
|
